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1. Introduction 
Transfer of long chain fatty acids through the 
inner membrane of mitochondria appears to require 
two pools of carnitine palmitoyl transferase (CPT), 
one latent, the other overt [l-5]. The relative pro- 
portions of these latent and overt forms of CTP has 
mainly been studied in liver mitochondria. A medium 
chain carnitine acyltransferase (COT, carnitine 
octanoyltransferase) has also been reported in heart 
and liver [6,7]. This activity appears to be distinct 
from CPT and from carnitine acetyltransferase (CAT), 
but its physiological role is uncertain. Until recently 
[8], it had not been established whether COT in heart 
or liver mitochondria showed latency. 
There has been considerable interest in the obser- 
vation that overt CPT activity in liver mitochondria is 
potently inhibited by malonyl CoA [9]. CPT activity 
in heart mitochondria [8] and COT in liver [lo] and 
heart [8] mitochondria are also extremely sensitive to 
malonyl CoA. It was therefore of interest to investi- 
gate the sensitivity of these activities to malonyl CoA 
in a wide range of tissues to see if regulation by this 
effector has general applicability. The relative activi- 
ties of the latent and overt forms of CPT and COT 
have also been measured and are found to vary widely 
from tissue to tissue. 
2. Materials and methods 
Coenzyme A thioesters were from PL-Biochemi- 
cals, oxaloacetate from Boehringer and Lcarnitine 
from Sigma. Tissues were obtained from male 
ElsevierfNorth-Holland Biomedical Press 
Sprague-Dawley rats (160-180 g) except for mam- 
mary gland which was from female Sprague-Dawley 
rats in peak lactation (12 days) suckling their first lit- 
ter. Single livers, kidney cortexes from 2 rats, hearts 
from 4 rats or mammary gland from a single rat were 
homogenised in ice-cold 0.25 M sucrose medium con- 
taining 10 mM Tris-HCl (pH 7.4) defatted albumin 
(10 mg/ml) and 1 mM EGTA using a Potter-Elvejhem 
homogeniser fitted with a motor-driven teflon pestle 
(radical clearance, 0.2 mm). Before homogenisation, 
mammary gland was forced through a tissue press. 
Muscle, containing as far as possible red fibres, was 
collected from the rear legs of 3 rats and homogenised 
as above except that 0.15 M KCl containing 10 mM 
Tris-HCl (pH 7.4) defatted albumin (10 mg/ml) and 
1 mM EGTA was substituted for the sucrose-Tris 
homogenisation buffer. Adipocytes were isolated by 
disaggregation of the epididymal fat pads of ten rats 
using collagenase [ 1 l] and were broken by swirling in 
a glass tube on a vortex mixer [ 121 with 30 ml ice-cold 
0.25 M sucrose 10 mM Tris-HCl (PH 7.4) defatted 
albumin (10 mg/ml), 1 mM EGTA. Mitochondria 
from all tissues were isolated and washed as in [lo]. 
Washing of all types of mitochondria was with 0.25 M 
sucrose, 10 mM Tris-HCl (pH 7.4), 1 mM EGTA. 
Finally, the mitochondria were resuspended in 0.3 M 
sucrose, 10 mM Tris-HCl (pH 7.4), 1 mM EGTA. 
The protein content of these stock mitochondrial 
suspensions was determined [ 13 ] using bovine serum 
albumin as standard and was found to be (means val- 
ues as mg/ml): liver, 4.0; kidney cortex, 3.4; adipo- 
cyte, 2.0; mammary gland, 3.3; skeletal muscle, 4.0; 
heart, 2.7. 
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For assay of CPT (EC 2.3.1.21) 50 ~1 fresh whole 
mitochondria or of mitochondria subjected to sonica- 
tion for 2 min were preincubated at 25°C in 1 .O ml 
containing 220 mM sucrose, 40 mM KCl, 10 mM 
Tris-HCl (pH 7.4), 1 mM EGTA, defatted albumin 
(1.3 mg/ml), 0.5 mM dithiothreitol, 40 PM palmitoyl 
CoA and the required concentration of malonyl CoA. 
The reaction was initiated by addition of 20 ~1 contain- 
ing 0.4 I.tmol Lcarnitine and 1 I.tCi D,L[methy13H] 
carnitine. After 4 min the reaction was terminated 
with 1 ml ice-cold 1.2 M HCl followed by 2 ml of 
water-saturated butanol. After mixing and brief cen- 
trifugation, the butanol layer was washed with 5 ml 
butanol-saturated water and 0.1 ml of the butanol 
layer, containing acyl [3H]carnitine taken for liquid 
scintillation during counting. Zero time blanks were 
measured and subtracted. 
COT was assayed as for CPT except that 40 MM 
CoA was substituted for palmitoyl CoA. 
Carnitine acetyltransferase (CAT, EC 2.3.1.7) and 
citrate synthase (EC 4.1.3.7) were assayed spectro- 
photometrically at 412 nm and 25’C in whole and 
sonicated mitochondria in 1 .O ml containing 220 mM 
sucrose, 40 mM KCl, 10 mM Tris-HCl (pH 7.4) 
1 mM EGTA, defatted albumin (1.3 mg/ml), 50 E.IM 
acetyl CoA and 0.1 mM 5,5’-dithiobis-(2-nitrobenzoic 
acid) (DTNB). CAT assays were initiated by addition 
of 400 nmol L-carnitine and citrate synthase by addi- 
tion of 60 nmol oxaloacetate. 
3. Results and discussion 
Fig.1 shows that overt CPT activities in all the 
tested tissues were inhibited by malonyl CoA. How- 
ever, there was a clear distinction between heart and 
skeletal muscle on one hand and liver, kidney cortex 
and mammary gland on the other in that malonyl 
CoA was effective at concentrations l-2 orders of 
magnitude lower in the former types of mitochon- 
dria. For these 5 types of mitochondria, plots of 
(percentage inhibition by malonyl CoA)-’ vs (malonyl 
CoA concentration)-’ were linear, suggesting a hyper- 
bolic-type relationship between the concentration of 
malonyl CoA and the effect of this inhibitor. Overt 
CPT in adipocyte mitochondria was anomalous in 
that the above relationship was not obeyed over the 
whole of the tested range of malonyl CoA concentra- 
tions. It may be seen in fig.1 that the response of 
adipocyte CPT to malonyl CoA appears to be a com- 
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Fig.1. Effect of malonyl CoA on overt CPT activity. CPT 
assays were performed with whole mitochondria. The values 
are expressed as percentage of the activities shown in table 1 
and are the means of the number of experiments hown in 
table 1. (0) Liver; (9) kidney cortex; (A) adipocyte; (A) mam- 
mary gland; (0) skeletal muscle; (o) heart. 
bination of a highly sensitive component (muscle-like) 
and a less sensitive component (liver or kidney-like). 
It is tempting to speculate that heart and skeletal 
muscle mitochondria might contain an isoenzyme of 
CPT differing from that found in the liver or kidney 
cortex. If this were so, the adipocyte activity might 
be a composite of these. It is noteworthy that liver 
and heart CPT differ from each other in a number of 
other properties [8]. 
We are unaware of any measurement of malonyl 
CoA levels in tissues other than liver at the present 
time. It is reasonable to expect this metabolite to be 
present in lipogenic tissues such as adipocytes or lac- 
tating mammary gland. A role for malonyl CoA in 
heart, kidney or skeletal muscle is less certain. How- 
ever, any condition, whether normal or pathological 
in which malonyl CoA was formed in these tissues 
should be associated with inhibition of CPT. Such an 
effect could be particularly profound in the heart or 
in skeletal muscle. 
Fig.2 shows that overt COT activity in skeletal 
muscle and heart mitochondria was inhibited by 
malonyl CoA concentrations similar to those that 
inhibit CPT in these tissues. However, only -50% of 
this COT activity appeared to be inhibitable. Kidney 
COT was more sensitive to malonyl CoA than kidney 
CPT by -1 order of magnitude. As shown in [lo], 
liver COT was inhibited by malonyl CoA, but there 
appeared to be two components to this inhibition 
curve. Mammary gland COT was barely affected by 
malonyl CoA. 
The data shown in fig.l,2 were normalised values 
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Fig.2. Effect of malonyl CoA on overt COT activity. COT 
activities were performed with whole mitochondria. The val- 
ues are expressed as percentages of the activities shown in 
table 1 and are the means of the number of experiments 
shown in table 1. Symbols are as for fig.1. 
obtained by expression of the activities in the absence 
of malonyl CoA as 100%. Table 1 shows that the 
absolute values of these activities varied considerably 
between the different mitochondrial types. Heart and 
skeletal muscle overt CPT activities were the highest 
and represented a large proportion of the total that 
was measurable after sonication. Liver and kidney 
cortex CPTs were intermediate in activity. Liver 
and kidney differed however in that a quite large 
proportion of the liver activity was latent whereas 
in the kidney most of the activity appeared to be 
overt. Adipocyte and mammary gland overt CPT 
activities were low and a very large proportion of 
the total CPT in these tissues was latent. There was 
no general parallelism between the overt or latent 
activities of COT compared with CPT between the 
various tissues, nor was there any parallelism between 
CPT and COT in the extent to which the ratio of 
overt/latent activities varied from tissue to tissue. It 
is particularly noteworthy that in kidney all the COT 
appeared to be overt and that in skeletal muscle or 
heart latent COT exceeded the overt activity whereas 
the opposite was found for CPT in these tissues. 
Citrate synthase and carnitine acetyl transferase 
activities were measured in an assay medium similar 
in composition to that used for CPT and COT. In gen- 
eral these activities were increased 21 O-fold by soni- 
cation suggesting that reasonable intactness of the 
mitochondria was retained. Palmitoyl CoA at 40 PM, 
which was used in the assay of CPT, did not appear 
to diminish the latency of citrate synthase. The 
possibility that this concentration of palmitoyl CoA 
might render the mitochondria ‘leaky’ and thereby be 
the cause of the smallness of the latent proportion of 
Table 1 
Activities of CPT, COT, CAT and citrate synthase in mitochondria 
CPT COT CAT Citrate synthase 
with 40 PM 
palmitoyl CoA 
Overt 
Liver 141 
Kidney 141 
Adipocyte 151 
Mammary gland [4] 
Skeletal muscle [4] 
Heart [41 
Total 
Liver [41 
Kidney [41 
Adipocyte I51 
Mammary gland [4] 
Skeletal muscle [4] 
Heart [41 
2.90 * 0.35 3.65 f 0.22 
2.15 * 0.22 3.71 + 0.05 
0.64 f 0.07 1.30 f 0.35 
0.34 * 0.08 0.39 f 0.06 
6.73 f 0.31 2.72 f 0.26 
9.33 f 0.37 3.77 + 0.11 
6.84 f 0.63 5.98 f 0.31 
3.45 + 0.34 3.59 + 0.44 
9.46 t 1.52 6.38 f 1.34 
7.34 f 0.14 3.16 + 0.55 
8.07 f 0.31 6.52 + 0.41 
16.18 f 0.15 8.63 + 0.11 
_ 
2.80 + 0.31 
- 
0 
7.25 f 1.26 
7.80 + 2.21 
- 
20.51 * 2.24 
- 
4.30 t 1.28 
82.3 + 2.9 
72.0 + 11.1 
2.79 ?: 0.42 
13.0 i: 1.8 
55.6 + 6.9 
47.1 f: 6.0 
55.0 f 2.0 
34.7 * 1.1 
118 + 4 
- 
688 * 88 
520 f 21 
649 f 16 
2.53 r 0.17 
13.9 f. 2.3 
_ 
52.6 f 4.5 
45.7 f 5.1 
51.1 + 1.2 
33.6 + 1.5 
115 +3 
_ 
659 + 93 
502 f 17 
578 f: 4 
Overt activities were measured with freshly prepared whole mitochondria. Total activities were measured after sonication of mito- 
chondria for 2 min. The values are means f SEM of the no. expt in brackets and are expressed as nmol . min-’ . mg mitochondrial 
protein-’ 
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the CPT in kidney, heart or skeletal muscle can there- 
fore be discounted. 
The proportion of CPT that is latent in this study 
in liver, adipocyte or heart mitochondria is somewhat 
larger than found in other studies [8,14] in which a 
DTNB-linked assay was used. Also the sensitivity of 
heart CPT to malonyl CoA reported here is greater 
than found in [8] with a DTNB-linked assay. DTNB 
appears to diminish the sensitivity of CPT to malonyl 
CoA and to increase the proportion of the total CPT 
that is overt (E. D. S., unpublished). 
This study demonstrates considerable differences 
between different mitochondrial types with regard to 
the intramitochondrial distribution of CPT and COT 
and the sensitivity of these activities to malonyl CoA. 
Presumably these findings are of physiological signifi- 
cance, but at present this is unclear. 
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